Researcher
Karel Fostier
- Keywords:Medicine
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Hematology (Department)
Member
From1 Jan 2013 → Today - Hematology (Department)
Member
From1 Feb 2019 → 13 Feb 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2015 → 30 Nov 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2015 → 2 Dec 2015 - Internal medicine (Department)
Member
From1 Sep 2010 → 31 Dec 2012 - Internal medicine (Department)
Member
From1 Jul 2009 → 31 Aug 2009 - Physiology (Department)
Member
From1 Oct 2006 → 30 Jun 2009 - Physiology (Department)
Member
From1 Oct 2006 → 30 Jun 2009 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From1 Sep 2006 → 19 Mar 2021
Publications
11 - 20 of 24
- Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells(2016)
Authors: Susanne Lub, Anke Maes, Karel Fostier, Alboukadel Kassambara, Jérôme Moreaux, D. Hose, Xavier Leleu, Randall W King, E Van Valckenborgh
Pages: 4062-4076 - An unexpected complication of chronic myelomonocytic leukemia(2016)
Authors: Jerrold Spapen, Karel Fostier
Pages: 1-4 - Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation(2014)
Authors: Brenda De Keersmaecker, Karel Fostier, Jurgen Corthals, Sofie Wilgenhof, Carlo Heirman, Joeri L Aerts, Kris Thielemans, Rik Schots
Pages: 1023-1036 - Cellular immunotherapy in multiple myeloma: Lessons from preclinical models(2014)
Authors: Marilene Binsfeld, Karel Fostier, J. Muller, F. Baron, Rik Schots, Yves Beguin, R Heusschen, Jo Caers
Pages: 392-404 - The IGF-1 receptor inhibitor picropodophyllin potentiates the
anti-myeloma activity of a BH3-mimetic.(2014)
Authors: Liesbeth Bieghs, Susanne Lub, Karel Fostier, E Van Valckenborgh, He Johnsen, Mette Nyegaard, H Jernberg-Wiklund
Pages: 11193-11208 - Immunomodulatory drugs: new developments(2013)
Authors: Karel Fostier
Pages: 21-28 - Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model(2013)
Authors: Haneen Nur, Karel Fostier, Sandrine Aspeslagh, Wim Renmans, Elisabeth Bertrand, Xavier Leleu, Mérédis Favreau, Karine Breckpot, Rik Schots, Marc De Waele, et al.
- The IGF-1 receptor inhbitor picropodophyllin (PPP) potentiates the anti-myeloma effects of the BH3 mimetic ABT-737.(2013)
Authors: Liesbeth Bieghs, E Van Valckenborgh, Martin Overgaard, He Johnsen, Mette Nyegaard, Karel Fostier, O. Larsson, Helena Jernberg-Wiklund
Pages: 26-26 - miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells(2013)
Authors: Gang Chen, Ijeoma Umelo, Shasha Lv, Erik Teugels, Karel Fostier, Peter Kronenberger, Alex Dewaele, Jan Sadones, Caroline Geers, Jacques De Grève
- Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma(2012)
Authors: Karel Fostier
Pages: 237-244